FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+29.59%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$1.52B
AUM Growth
+$1.52B
(+15%)
Cap. Flow
-$19.6M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$5 |
Top Sells
| 1 |
Denali Therapeutics
DNLI
|
$19.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $1.03B | 67.56% |
9,666,038
| – | – |
|
2
Sana Biotechnology
SANA
$777M
| $250M | 16.4% |
25,001,856
| – | – |
|
|
OMGA
3
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $107M | 7% |
29,225,579
| – | – |
|
4
Foghorn Therapeutics
FHTX
$286M
| $85M | 5.58% |
12,674,120
| – | – |
|
|
5
Denali Therapeutics
DNLI
$2.23B
| $28M | 1.84% |
1,364,516
-955,452
| -41% | -$19.6M |
|
6
Seres Therapeutics
MCRB
$166M
| $17.9M | 1.17% |
23,117,045
| – | – |
|
|
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.92M | 0.45% |
1,293,849
+1
| +0% | +$5 |
|